InfoComm 2023: Integrators Are This Year’s Litmus Test for Designing & Launching Quality AV Products

 

The time is now! InfoComm 2023 is in full swing in Orlando, Florida. Every AV brand and professional worth their salt is getting their steps in at the Orange County Convention Center to ask an essential question: How are major trends in technology, the macroeconomy, and the internal dynamics of our industry shaping opportunities and challenges in AV for the next year?

One of the key trends that’s been guiding AV product design and business strategy over the last few years is the end-user experiences. From themed entertainment and K-12 classrooms, to houses of worship and retail brick & mortars, industries where AV is an essential part of operations are becoming increasingly user-centric with more 1:1 technology, mobile integrations, and personalized experiences. In this reality, it’s the foot soldiers—the integrators and installers—who turn theory into practice for AV brands and their product designers. Feedback from the integrator experience not only enhances brands’ product development, but also significantly influences market acceptance of new cutting edge AV integrations.

This healthy back and forth between product developers and integrators is what’s on the radar of leading audio solution providers like AtlasIED as they showcase on the InfoComm 2023 show floor. Jon Stembel, Product Manager at AtlasIED, shared his thoughts with Pro AV Today on why this focus on integrator feedback is such a priority for AtlasIED at this year’s show.

 

Jon’s Thoughts

“With the integrators, they’re a great classroom for us to study from. These are the guys here on the front lines. These are the guys getting on the ladders and doing the installations, and they’re the ones that are in front of the end customers, the people actually writing the checks. So we lean on them very heavily, both up front on projects where we’re defining speakers, but also on the back end when we’re getting closer to launching. We want those guys to say, yes, this will meet our needs. This will suffice for our schools or for our Hi-Fi, whatever the use case is, we want them to give us the go-ahead before we put them out the door.”

 

Article written by Daniel Litwin.

Follow us on social media for the latest updates in B2B!

Image

Latest

AI in marketing
From Queries to Conversations with AI in Marketing Analytics
April 21, 2025

In this episode of the SparkCast, Aby Varma—founder of Spark Novus, a firm that helps marketing leaders adopt AI responsibly and strategically—sits down with Daniel Kravtsov, CEO and Co-Founder of Improvado. Daniel shares his unique journey from Russia to founding a cutting-edge martech company in the Bay Area. Together, they explore how AI agents…

Read More
ESA
ESA Success Requires Strategy, Infrastructure, and Support Beyond Legislation
April 21, 2025

As education savings accounts (ESAs) gain traction across the United States, the conversation is shifting from policy debates to the complexities of implementation. Fueled by post-pandemic dissatisfaction with traditional school models and a desire for more customizable educational options, ESAs are being adopted in a growing number of states, often under “universal” frameworks. But…

Read More
supply chain data analytics
Supply Chain Data Analytics Fails Without Clean Data, Ventagium Delivers the Fix
April 21, 2025

Supply chain leaders face an overwhelming volume of siloed data across ERPs, TMS platforms, and warehouse systems, yet few know how to align it for smarter decisions. The stakes are rising fast. According to Capgemini’s 2024 report Data: A Powerful Ally in Tackling Scope 3 Emission Reduction Targets, 85% of organizations cite data access…

Read More
cancer immunotherapy
What’s Next in Preclinical Cancer Immunotherapy Research?
April 19, 2025

As the field of cancer immunotherapy rapidly evolves, researchers are turning to next-generation in vitro technologies to replicate the complexities of the tumor microenvironment with unprecedented fidelity. Organoid platforms and ex vivo patient-derived tissue models are transforming how scientists approach preclinical testing, offering deeper mechanistic insights and better predictive power for therapeutic response. With immunotherapies…

Read More